专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US5725961A Recording medium having ink-absorbent layer 失效
标题翻译：具有吸墨层的记录介质
公开(公告)号：US5725961A
公开(公告)日：1998-03-10
申请号：US720772
申请日：1996-10-03
申请人： Yoshiyuki Ozawa , Hideo Yamazaki , Kenji Kawada , Tetsuya Ochiai
发明人： Yoshiyuki Ozawa , Hideo Yamazaki , Kenji Kawada , Tetsuya Ochiai
IPC分类号： B41M5/00 , B05D5/04 , B05D7/04 , B05D7/24 , B41J2/01 , B41M5/50 , B41M5/52 , D21H19/20
CPC分类号： B41M5/5254 , Y10T428/265
摘要： A recording medium is provided which causes none of bleeding or feathering, cracking and whitening of a print and is suitably usable especially for ink jet recording. The recording medium, when used in a system where an image is viewed by taking advantage of transmitted light, such as a system using an OHP sheet, can realize a good image having high light transmittance and high brightness. The recording medium comprises a substrate bearing an ink-absorbent layer, the ink-absorbent layer being formed of a polymer complex of a basic polymer and a styrene/(meth)acrylic acid polymer, the mixing ratio of the basic polymer and the styrene/(meth)acrylic acid polymer being in the range of from 10:3.5 to 7.
摘要翻译：提供了一种记录介质，其不引起印刷品的渗色或羽化，开裂和变白，并且特别适用于喷墨记录。记录介质在利用透过光等观看图像的系统中使用时，例如使用OHP片的系统，可以实现具有高透光率和高亮度的良好图像。该记录介质包括一个带有吸墨层的基片，该吸墨层由一种碱性聚合物和一种苯乙烯/（甲基）丙烯酸聚合物的聚合物复合物形成，碱性聚合物与苯乙烯/ （甲基）丙烯酸聚合物的范围为10:3.5至7。

2. 发明授权

US06476083B1 Alumina dispersant, alumina dispersion liquid, agent for treating inkjet-printing materials, and inkjet-printing materials 失效
标题翻译：氧化铝分散剂，氧化铝分散液，喷墨印刷材料处理剂和喷墨印刷材料
公开(公告)号：US06476083B1
公开(公告)日：2002-11-05
申请号：US09310143
申请日：1999-05-12
申请人： Kousuke Okura , Tetsuya Ochiai , Kenji Kawada
发明人： Kousuke Okura , Tetsuya Ochiai , Kenji Kawada
IPC分类号： B01F1700
CPC分类号： B82Y30/00 , B01F17/0042 , B01J13/0034 , B01J13/0047 , B41M5/5218 , B41M5/5227 , B41M5/5254 , B41M5/529 , C01F7/026 , C01P2004/62 , C01P2004/64 , C01P2006/22
摘要： This invention provides an alumina dispersant mainly comprised of a nitrogen-containing monocarboxylic acid, an alumina dispersion liquid comprised of alumina particles dispersed well in an aqueous dispersing medium, a treating agent for use in making inkjet-printing materials, comprised of the alumina dispersion, and the inkjet-printing materials prepared by using the treating agent to have a high glossiness, high absorption, high water resistance, high reproducibility and good roundness of dots.
摘要翻译：本发明提供主要由含氮一元羧酸组成的氧化铝分散剂，由水分散介质中充分分散的氧化铝颗粒构成的氧化铝分散液，用于制造喷墨印刷材料的处理剂，由氧化铝分散体，并且通过使用处理剂制备的喷墨印刷材料具有高光泽度，高吸收性，高耐水性，高再现性和圆点圆形性。

3. 发明授权

US07957195B2 Semiconductor device 有权
标题翻译：半导体器件
公开(公告)号：US07957195B2
公开(公告)日：2011-06-07
申请号：US12630295
申请日：2009-12-03
申请人： Masamichi Fujito , Makoto Mizuno , Takahiro Yokoyama , Kenji Kawada , Takashi Iwase , Yasunobu Aoki , Takashi Kurafuji , Tomohiro Uchiyama , Shuichi Sato , Yuji Uji
发明人： Masamichi Fujito , Makoto Mizuno , Takahiro Yokoyama , Kenji Kawada , Takashi Iwase , Yasunobu Aoki , Takashi Kurafuji , Tomohiro Uchiyama , Shuichi Sato , Yuji Uji
IPC分类号： G11C16/00
CPC分类号： G11C7/04 , G11C16/0441 , G11C16/10 , G11C16/28
摘要： The semiconductor device includes a nonvolatile memory, having a memory array containing 1-bit twin cells, each composed of electrically rewritable first and second storage devices, the first and second storage devices holding binary data according to difference of their threshold voltages, and having different retention characteristics depending on difference of the binary data thereof; a read circuit for differentially amplifying complementary data output from the first and second storage devices of the twin cell selected for read, and judging information stored in the twin cell; and a control circuit. Two memory cells constituting a twin cell are arranged to hold different data. Therefore, even when the retention performance of one memory cell deteriorates, the difference between data held by the two memory cells can be maintained. Hence, differential amplification of such difference enables acquisition of proper stored information. Thus, retention performance of an electrically rewritable nonvolatile memory cell is improved.
摘要翻译：半导体器件包括非易失性存储器，具有包含1比特双胞胞的存储器阵列，每个存储器阵列由电可重写的第一和第二存储器件组成，第一和第二存储器件根据其阈值电压的差异保持二进制数据，并具有不同的保留特性取决于其二进制数据的差异; 用于差分放大从被选择读取的双胞胎的第一和第二存储装置输出的互补数据的读取电路，以及判断存储在双胞胎中的信息; 和控制电路。布置构成双胞胎的两个存储单元以保存不同的数据。因此，即使一个存储单元的保持性能劣化，也能够维持由两个存储单元保持的数据之间的差异。因此，这种差异的差分放大使得能够获得正确的存储信息。因此，提高了电可重写非易失性存储单元的保持性能。

4. 发明授权

US4420377A Method for continuously electroplating wire or the like and apparatus therefor 失效
标题翻译：连续电镀线等的方法及其装置
公开(公告)号：US4420377A
公开(公告)日：1983-12-13
申请号：US260779
申请日：1981-05-05
申请人： Shoji Shiga , Akitoshi Suzuki , Yasuo Goma , Kenji Kawada
发明人： Shoji Shiga , Akitoshi Suzuki , Yasuo Goma , Kenji Kawada
IPC分类号： C25D7/06 , C25D17/06
CPC分类号： C25D7/0607
摘要： Method and apparatus for continuously electroplating wire or the like wherein two or more drums combine a power supply with a wire turn direction, each drum having a vertical and rotatable shaft, are provided; a wire or the like to be electroplated is wound on the drums in multiple stages so as to be run; an electroplating cell is positioned between the drums so that the wire to be electroplated is arranged to pass in and out of the electroplating cell in multiple stages and repeatedly; and, particularly, an end of the electroplating cell is provided with a slit for passage of the wire to be electroplated, the slit being provided with weir plates placed one on top of another such that the weir plates put each of wires in multiple stages running through the electroplating cell between upper and lower weir plates and passage holes for running the wires at multiple stages are formed at joints between individual weir plates.
摘要翻译：提供用于连续电镀线等的方法和装置，其中两个或更多个鼓组合电源与线转方向，每个鼓具有垂直和可旋转的轴; 要电镀的线等以多个阶段缠绕在鼓上以便运行; 电镀槽位于鼓之间，使得要电镀的电线被布置成多次并重复地进出电镀电池; 特别地，电镀单元的端部设置有用于电镀线的通道的狭缝，该狭缝设置有一个放置在另一个之上的堰板，使得堰板将每根导线放置在多个级中通过上堰板和下堰板之间的电镀槽，在各个堰板之间的接头处形成用于在多个阶段运行导线的通孔。

5. 发明授权

US07008954B1 Th2 differentiation inhibitors 失效
标题翻译： Th2分化抑制剂
公开(公告)号：US07008954B1
公开(公告)日：2006-03-07
申请号：US09980475
申请日：2000-07-14
申请人： Akinori Arimura , Kenji Kawada
发明人： Akinori Arimura , Kenji Kawada
IPC分类号： A61K31/09 , A61K31/136 , A61K31/15
CPC分类号： C07C251/58 , A61K31/05 , A61K31/075 , A61K31/095 , A61K31/135 , A61K31/136 , A61K31/15 , A61K31/235 , A61K31/44 , A61K31/4418 , A61K31/495 , A61K31/50 , A61K31/505 , C07C211/50 , C07C217/80
摘要： The present invention provides a pharmaceutical composition for use as a Th2 differentiation inhibitor comprising a compound represented by Formula (I): wherein each of ring A, ring B and ring C is an aromatic carbocyclic ring, a heterocyclic ring and the like, X is a single bond, —O—, —CH2—, —NH—, —SO— and the like, Y is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl and the like, each of V1 and V2 is a single bond, —O—, —NH—, —OCH2— and the like, a prodrug, pharmaceutically acceptable salt or solvate thereof.
摘要翻译：本发明提供一种用作Th2分化抑制剂的药物组合物，其包含由式（I）表示的化合物：其中环A，环B和环C各自为芳族碳环，杂环等，X为单键，-O-，-CH 2 - ， - NH - ， - SO-等，Y是氢，任选取代的低级烷基，任选取代的低级烯基等， V 1和V 2是单键，-O - ， - NH - ， - OCH 2 - 等，前药，其药学上可接受的盐或溶剂合物。

6. 发明授权

US5292754A Treatment for hypertension or glaucoma in eyes 失效
标题翻译：治疗眼内高血压或青光眼
公开(公告)号：US5292754A
公开(公告)日：1994-03-08
申请号：US948179
申请日：1992-09-21
申请人： Morio Kishi , Kimio Takahashi , Kenji Kawada , Yasumasa Goh
发明人： Morio Kishi , Kimio Takahashi , Kenji Kawada , Yasumasa Goh
IPC分类号： C07C405/00 , A61K31/557
CPC分类号： C07C405/00 , Y10S206/828 , Y10S514/913
摘要： The present invention relates to a method for treating hypertension or glaucoma in the eye comprising contacting the surface of the eye with a therapeutic amount of a 15-deoxyprostaglandin derivative of the formula (I): ##STR1## in which ##STR2## is a 5 membered ring which is selected from a group consisting of ##STR3## R.sup.1 is hydrogen or lower alkyl; R.sup.2 is C.sub.6 -C.sub.12 alkyl, C.sub.6 -C.sub.12 alkenyl or C.sub.6 -C.sub.12 alkadienyl or a pharmaceutically acceptable salt thereof. The invention also relates to a kit for delivery of a topical solution for treatment of glaucoma which comprises (a) container having a solution including a compound of the formula (I), and (b) means for topical delivery of said solution to the eye in a controlled dosage.
摘要翻译：本发明涉及一种用于治疗眼睛中的高血压或青光眼的方法，包括使眼表面与治疗量的式（I）的15-脱氧前列腺素衍生物接触：（*化学结构*）（I），其中（*化学结构*）是选自（*化学结构*）R 1为氢或低级烷基的5元环; R2是C6-C12烷基，C6-C12链烯基或C6-C12链二烯基或其药学上可接受的盐。本发明还涉及一种用于递送用于治疗青光眼的局部用溶液的试剂盒，其包含（a）具有包含式（I）化合物的溶液的容器，和（b）将所述溶液局部递送至眼睛的装置以受控剂量。

7. 发明授权

US08174901B2 Semiconductor integrated circuit device 有权
标题翻译：半导体集成电路器件
公开(公告)号：US08174901B2
公开(公告)日：2012-05-08
申请号：US12721553
申请日：2010-03-10
申请人： Ken Matsubara , Hideo Kasai , Kenji Kawada , Makoto Mizuno
发明人： Ken Matsubara , Hideo Kasai , Kenji Kawada , Makoto Mizuno
IPC分类号： G11C11/34
CPC分类号： G11C7/02 , G11C16/06 , G11C16/32 , G11C16/3418
摘要： This invention is to reduce the number of memory gate drivers, while lessening the number of times of disturb occurrence in a memory array configuration that implements writing in small byte units. A memory array comprises a plurality of sub-arrays, MG transfers, SL drivers, and CG drivers. Each sub-array includes a plurality of memory gate lines, control gate lines, source lines, and bit lines. Memory cells are arranged in positions of intersections of these lines. The control gate lines, CG drivers, source lines, and SL drivers are common to the sub-arrays, whereas the memory gate lines and MG buffer circuits are provided for each sub-array. Thereby, the units in which data is written are decreased and adverse effects of disturb are reduced without increasing the circuit size of the memory array.
摘要翻译：本发明是减少存储器栅极驱动器的数量，同时减少以小字节为单位实现写入的存储器阵列配置中的干扰发生次数。存储器阵列包括多个子阵列，MG传输，SL驱动器和CG驱动器。每个子阵列包括多个存储器栅极线，控制栅极线，源极线和位线。存储单元布置在这些线的相交位置。控制栅极线，CG驱动器，源极线和SL驱动器对于子阵列是共同的，而为每个子阵列提供存储器栅极线和MG缓冲电路。因此，数据写入的单元减少，并且不增加存储器阵列的电路尺寸的同时降低了干扰的不利影响。

8. 发明申请

US20110208904A1 SEMICONDUCTOR DEVICE 有权
标题翻译：半导体器件
公开(公告)号：US20110208904A1
公开(公告)日：2011-08-25
申请号：US13099720
申请日：2011-05-03
申请人： Masamichi Fujito , Makoto Mizuno , Takahiro Yokoyama , Kenji Kawada , Takashi Iwase , Yasunobu Aoki , Takashi Kurafuji , Tomohiro Uchiyama , Shuichi Sato , Yuji Uji
发明人： Masamichi Fujito , Makoto Mizuno , Takahiro Yokoyama , Kenji Kawada , Takashi Iwase , Yasunobu Aoki , Takashi Kurafuji , Tomohiro Uchiyama , Shuichi Sato , Yuji Uji
IPC分类号： G06F12/00
CPC分类号： G11C7/04 , G11C16/0441 , G11C16/10 , G11C16/28
摘要： The semiconductor device includes a nonvolatile memory, having a memory array containing 1-bit twin cells, each composed of electrically rewritable first and second storage devices, the first and second storage devices holding binary data according to difference of their threshold voltages, and having different retention characteristics depending on difference of the binary data thereof; a read circuit for differentially amplifying complementary data output from the first and second storage devices of the twin cell selected for read, and judging information stored in the twin cell; and a control circuit. Two memory cells constituting a twin cell are arranged to hold different data. Therefore, even when the retention performance of one memory cell deteriorates, the difference between data held by the two memory cells can be maintained. Hence, differential amplification of such difference enables acquisition of proper stored information. Thus, retention performance of an electrically rewritable nonvolatile memory cell is improved.
摘要翻译：半导体器件包括非易失性存储器，具有包含1比特双胞格的存储器阵列，每个存储器阵列由电可重写的第一和第二存储器件组成，第一和第二存储器件根据其阈值电压的差异保持二进制数据，并且具有不同的保留特性取决于其二进制数据的差异; 用于差分放大从被选择读取的双胞胎的第一和第二存储装置输出的互补数据的读取电路，以及判断存储在双胞胎中的信息; 和控制电路。布置构成双胞胎的两个存储单元以保存不同的数据。因此，即使一个存储单元的保持性能劣化，也能够维持由两个存储单元保持的数据之间的差异。因此，这种差异的差分放大使得能够获得正确的存储信息。因此，提高了电可重写非易失性存储单元的保持性能。

9. 发明授权

US07220783B2 Para-terphenyl compounds 失效
标题翻译：对三联苯化合物
公开(公告)号：US07220783B2
公开(公告)日：2007-05-22
申请号：US10704876
申请日：2003-11-12
申请人： Kenji Kawada , Mitsuaki Ohtani , Ryuji Suzuki , Akinori Arimura
发明人： Kenji Kawada , Mitsuaki Ohtani , Ryuji Suzuki , Akinori Arimura
IPC分类号： A61K31/075 , A61K31/09 , C07C43/205 , C07C43/225 , C07C43/23
CPC分类号： C07D213/30 , C07C15/14 , C07C43/225 , C07C43/23 , C07C43/253 , C07C43/315 , C07C45/68 , C07C47/57 , C07C47/575 , C07C59/64 , C07C59/70 , C07C65/24 , C07C65/28 , C07C69/712 , C07C69/734 , C07C69/94 , C07C205/35 , C07C205/37 , C07C217/20 , C07C217/76 , C07C217/80 , C07C229/52 , C07C233/25 , C07C233/27 , C07C233/80 , C07C235/60 , C07C251/38 , C07C251/60 , C07C255/54 , C07C271/28 , C07C275/32 , C07C281/04 , C07C281/10 , C07C307/10 , C07C309/65 , C07C309/66 , C07C309/73 , C07C311/08 , C07C311/21 , C07C311/29 , C07C317/22 , C07C327/42 , C07D215/14 , C07D239/54 , C07D295/30 , C07D307/42 , C07D309/22 , C07D317/54 , C07D319/20 , C07D333/28 , C07D333/38 , C07D333/54 , C09K2019/123
摘要： The present invention provides a selective suppressor of the IgE production comprising a compound which suppresses the IgE production in a process from a differentiation of a mature B cell into an antibody-producing cell to the production of an antibody and which does not suppress or weakly suppresses the production of IgG, IgM and/or IgA which are produced at the same time, a compound of the formula (I): wherein R1–R13 are hydrogen, halogen, lower alkyl, lower alkoxy or the like, X is —O—, —CH2—, —NR14— or —S(O)p- and Y is lower alkyl, lower alkenyl or the like, a process for producing the same and a pharmaceutical composition comprising the same.
摘要翻译：本发明提供了IgE生产的选择性抑制剂，其包含抑制从成熟B细胞分化成抗体产生细胞至产生抗体并且不抑制或弱抑制的过程中的IgE产生的化合物同时产生的IgG，IgM和/或IgA的制备，式（I）的化合物：其中R 1 -R 13是氢，卤素，低级烷基，低级烷氧基等，X是-O-，-CH 2 - ， - NR 14 - 或-S（O）p-和Y 低级烷基，低级烯基等，其制备方法和含有该方法的药物组合物。

10. 发明授权

US5043456A 6-oxa and thiabicyclo [3.1.0.] compounds 失效
标题翻译： 6-氧杂和硫杂双环[3.1.0。]化合物
公开(公告)号：US5043456A
公开(公告)日：1991-08-27
申请号：US516141
申请日：1990-04-27
申请人： Mitsuaki Ohtani , Fumihiko Watanabe , Susumu Kamata , Nobuhiro Haga , Tatsuo Tsuri , Tadahiko Tsushima , Kenji Kawada
发明人： Mitsuaki Ohtani , Fumihiko Watanabe , Susumu Kamata , Nobuhiro Haga , Tatsuo Tsuri , Tadahiko Tsushima , Kenji Kawada
IPC分类号： C07D493/08 , A61K31/00 , A61K31/335 , A61K31/336 , A61K31/34 , A61K31/557 , A61P7/02 , A61P9/08 , A61P11/08 , C07C20060101 , C07C67/00 , C07C301/00 , C07C311/00 , C07C311/02 , C07C311/07 , C07C311/10 , C07C311/13 , C07C311/15 , C07C311/20 , C07C311/37 , C07C313/00 , C07C323/52 , C07D209/52 , C07D209/56 , C07D213/34 , C07D213/71 , C07D221/22 , C07D303/40 , C07D303/46 , C07D331/02 , C07D491/044 , C07D493/04 , C07D495/04
CPC分类号： C07D493/08 , C07D213/34 , Y02P20/55
摘要： There are provided compounds of the formula: ##STR1## wherein R.sub.1 is a hydrogen or C.sub.1 -C.sub.5 alkyl; R.sub.2 is an C.sub.1 -C.sub.10 alkyl, aryl, aralkyl, or pyridyl, where the aryl, aralkyl, or pyridyl are unsubstituted or are substituted by C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy, nitro, hydroxy, carboxy, amino, C.sub.1 -C.sub.5 alkylamino, C.sub.1 -C.sub.5 dialkyamino whose two alkyl groups may be different from each other, C.sub.2 -C.sub.3 alkanoylamino, or halogen and X is an C.sub.1 -C.sub.7 alkylene, C.sub.2 -C.sub.7 alkenylene, --CH(F)CH.dbd.CH(CH.sub.2).sub.3 --, --(CH.sub.2).sub.3 --S--(CH.sub.2).sub.2 --, --(CH.sub.2).sub.2 --S--(CH.sub.2).sub.3 --, --C.sub.6 H.sub.4 -O--CH.sub.2 -- or --CH.sub.2 CH.dbd.CH--m--C.sub.6 H.sub.4 --, or their pharmaceutically accepatble salts. The compounds are useful as antithrombotic, anti-vasconstricting and anti-bronchoconstricting drugs.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式